In addition, clinical trials have revealed a correlation between the level of HSP27 and aggressiveness of various cancers, metastatic properties, and the development of anticancer drug resistance, resulting in poor survival rates after chemotherapy and irradiation therapy [12,15,16]. The gene discussed is HSPB1; the disease is cancer.